FOXJ3 Antibody
-
中文名稱：FOXJ3兔多克隆抗體
-
貨號：CSB-PA008823GA01HU
-
規(guī)格：￥3,900
-
其他：
產(chǎn)品詳情
-
Uniprot No.：
-
基因名：FOXJ3
-
別名：Forkhead box J3 antibody; Forkhead box protein J3 antibody; FOXJ3 antibody; FOXJ3_HUMAN antibody; KIAA1041 antibody; MGC165036 antibody; MGC176686 antibody
-
宿主：Rabbit
-
反應種屬：Human
-
免疫原：Human FOXJ3
-
免疫原種屬：Homo sapiens (Human)
-
抗體亞型：IgG
-
純化方式：Antigen Affinity purified
-
濃度：It differs from different batches. Please contact us to confirm it.
-
保存緩沖液：PBS with 0.02% Sodium Azide, 50% Glycerol, pH 7.3. -20°C, Avoid freeze / thaw cycles.
-
產(chǎn)品提供形式：Liquid
-
應用范圍：ELISA,WB
-
Protocols：
-
儲存條件：Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
貨期：Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
-
用途：For Research Use Only. Not for use in diagnostic or therapeutic procedures.
產(chǎn)品評價
相關產(chǎn)品
靶點詳情
-
功能：Transcriptional activator of MEF2C involved in the regulation of adult muscle fiber type identity and skeletal muscle regeneration. Plays an important role in spermatogenesis. Required for the survival of spermatogonia and participates in spermatocyte meiosis.
-
基因功能參考文獻：
- FOXO3-dependent gene regulation is generally mediated not through uniquely bound regions but through regions occupied by both FOXK2 and FOXO3 where both factors play a regulatory role. PMID: 26578569
- This study demonstrated that miR-517a-3p promoted lung cancer cell proliferation and invasion by targeting of FOXJ3 expression PMID: 24846831
- FOXJ3 may be associated with the development of rheumatoid arthritis. PMID: 23933633
- FOXJ3 is identified as a novel cell cycle reguulator that may regulate a network of zinc finger proteins. PMID: 22740631
-
亞細胞定位：Nucleus.
-
數(shù)據(jù)庫鏈接：
Most popular with customers
-
-
YWHAB Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC, IF, FC
Species Reactivity: Human, Mouse, Rat
-
-
-
-
-
-
